SEC Form 10-Q filed by Solid Biosciences Inc.
$SLDB
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/8/2025 | $16.00 | Buy | Truist |
12/13/2024 | $16.00 | Outperform | Wedbush |
12/10/2024 | $15.00 | Mkt Outperform | JMP Securities |
7/15/2024 | $10.00 → $15.00 | Neutral → Overweight | JP Morgan |
6/24/2024 | $12.00 | Market Perform → Outperform | Leerink Partners |
5/31/2024 | $20.00 | Overweight | Piper Sandler |
3/28/2024 | $40.00 | Outperform | William Blair |
3/15/2024 | $16.00 | Buy | Citigroup |